An AI model may help identify patients with myelofibrosis at high risk of early death after transplant, according to an ...

After a median follow-up of 3.4 years, more than half (58%) of patients were still alive. allogeneic hematopoietic stem cell transplantation is feasible in myelofibrosis (MF), according to a new study ...

Research has shown that autologous hematopoietic stem cell transplantation is an effective treatment for MS. At 2 years and 4 years post-transplant, relapse-free survival rates were 94% and 89% ...

Stem cell therapies are a type of cell therapy in which the cells used are either stem cells (as in the case of bone marrow transplantation) or are derived from stem cells, as is this case with ...

The incidence of hemorrhagic cystitis (HC) in children with severe β-thalassemia undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) appears to be lower than that in patients ...

in allogeneic hematopoietic stem cell transplantation (allo-HSCT), highlighting the role of the recipient's circadian rhythms. The team was led by Prof. Zhan Cheng from the University of Science ...

Nearly half of DEC-C-Ven–treated patients proceeded to hematopoietic stem cell transplantation vs only 16% of those treated with DEC-C. The addition of venetoclax to oral decitabine-cedazuridine ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response ...

FRIDAY, April 4, 2025 (HealthDay News) -- For patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation (allo-HCT), machine learning (ML) enhances risk stratification ...

However, some patients may already have a reduced number of oocytes before transplantation because of the previous treatment received for a malignant disorder. The impact of reduced intensity ...